nodes	percent_of_prediction	percent_of_DWPC	metapath
Abacavir—UGT1A1—Ezetimibe—atherosclerosis	0.257	0.352	CbGbCtD
Abacavir—UGT1A1—Simvastatin—atherosclerosis	0.239	0.327	CbGbCtD
Abacavir—UGT1A1—Lovastatin—atherosclerosis	0.234	0.32	CbGbCtD
Abacavir—UGT1A1—Irinotecan Pathway—NPC1—atherosclerosis	0.00725	0.134	CbGpPWpGaD
Abacavir—ADK—Pitavastatin—Rosuvastatin—atherosclerosis	0.00643	1	CbGdCrCtD
Abacavir—ADH6—Phase 1 - Functionalization of compounds—CYP7A1—atherosclerosis	0.00437	0.081	CbGpPWpGaD
Abacavir—ADH6—Phase 1 - Functionalization of compounds—CYP27A1—atherosclerosis	0.00404	0.0749	CbGpPWpGaD
Abacavir—UGT1A1—Heme degradation—HMOX1—atherosclerosis	0.00238	0.0442	CbGpPWpGaD
Abacavir—ADH6—Biological oxidations—CYP7A1—atherosclerosis	0.00232	0.043	CbGpPWpGaD
Abacavir—ADH6—Biological oxidations—CYP27A1—atherosclerosis	0.00215	0.0398	CbGpPWpGaD
Abacavir—ADK—Purine metabolism—GPX1—atherosclerosis	0.00184	0.034	CbGpPWpGaD
Abacavir—UGT1A1—Porphyrin metabolism—HMOX1—atherosclerosis	0.00103	0.0192	CbGpPWpGaD
Abacavir—ADH6—Biological oxidations—GSTM1—atherosclerosis	0.000958	0.0178	CbGpPWpGaD
Abacavir—ADK—Nucleotide metabolism—GPX1—atherosclerosis	0.000922	0.0171	CbGpPWpGaD
Abacavir—UGT1A1—Estrogen metabolism—GSTM1—atherosclerosis	0.000921	0.0171	CbGpPWpGaD
Abacavir—Muscular weakness—Simvastatin—atherosclerosis	0.000837	0.004	CcSEcCtD
Abacavir—Hepatitis—Rosuvastatin—atherosclerosis	0.000828	0.00396	CcSEcCtD
Abacavir—Pharyngitis—Rosuvastatin—atherosclerosis	0.000822	0.00393	CcSEcCtD
Abacavir—UGT1A1—Aryl Hydrocarbon Receptor Pathway—AHR—atherosclerosis	0.000805	0.0149	CbGpPWpGaD
Abacavir—Liver function test abnormal—Niacin—atherosclerosis	0.000805	0.00385	CcSEcCtD
Abacavir—Pancreatitis—Simvastatin—atherosclerosis	0.000804	0.00385	CcSEcCtD
Abacavir—Liver function test abnormal—Pravastatin—atherosclerosis	0.000792	0.00379	CcSEcCtD
Abacavir—Bronchitis—Simvastatin—atherosclerosis	0.000789	0.00377	CcSEcCtD
Abacavir—Abdominal discomfort—Simvastatin—atherosclerosis	0.000787	0.00376	CcSEcCtD
Abacavir—Stevens-Johnson syndrome—Lovastatin—atherosclerosis	0.000775	0.00371	CcSEcCtD
Abacavir—Toxic epidermal necrolysis—Pravastatin—atherosclerosis	0.000773	0.0037	CcSEcCtD
Abacavir—Muscular weakness—Niacin—atherosclerosis	0.000769	0.00368	CcSEcCtD
Abacavir—Neuropathy peripheral—Lovastatin—atherosclerosis	0.000767	0.00367	CcSEcCtD
Abacavir—Alanine aminotransferase increased—Pravastatin—atherosclerosis	0.000757	0.00362	CcSEcCtD
Abacavir—Muscular weakness—Pravastatin—atherosclerosis	0.000757	0.00362	CcSEcCtD
Abacavir—Neuropathy peripheral—Ezetimibe—atherosclerosis	0.000752	0.0036	CcSEcCtD
Abacavir—Depression—Simvastatin—atherosclerosis	0.000729	0.00349	CcSEcCtD
Abacavir—Pancreatitis—Pravastatin—atherosclerosis	0.000727	0.00348	CcSEcCtD
Abacavir—Hepatobiliary disease—Ezetimibe—atherosclerosis	0.000725	0.00347	CcSEcCtD
Abacavir—Stevens-Johnson syndrome—Simvastatin—atherosclerosis	0.000725	0.00347	CcSEcCtD
Abacavir—Bronchitis—Niacin—atherosclerosis	0.000724	0.00347	CcSEcCtD
Abacavir—Neuropathy peripheral—Simvastatin—atherosclerosis	0.000717	0.00343	CcSEcCtD
Abacavir—Hepatitis—Lovastatin—atherosclerosis	0.000702	0.00336	CcSEcCtD
Abacavir—Hepatitis—Ezetimibe—atherosclerosis	0.000689	0.00329	CcSEcCtD
Abacavir—Pharyngitis—Ezetimibe—atherosclerosis	0.000683	0.00327	CcSEcCtD
Abacavir—ADH6—Metabolism—LDLRAP1—atherosclerosis	0.000679	0.0126	CbGpPWpGaD
Abacavir—Connective tissue disorder—Ezetimibe—atherosclerosis	0.000677	0.00324	CcSEcCtD
Abacavir—Erythema multiforme—Lovastatin—atherosclerosis	0.000664	0.00317	CcSEcCtD
Abacavir—Depression—Pravastatin—atherosclerosis	0.000659	0.00315	CcSEcCtD
Abacavir—Hepatitis—Simvastatin—atherosclerosis	0.000657	0.00314	CcSEcCtD
Abacavir—Stevens-Johnson syndrome—Pravastatin—atherosclerosis	0.000656	0.00314	CcSEcCtD
Abacavir—Stomatitis—Niacin—atherosclerosis	0.000655	0.00313	CcSEcCtD
Abacavir—Acute coronary syndrome—Pravastatin—atherosclerosis	0.000652	0.00312	CcSEcCtD
Abacavir—Erythema multiforme—Ezetimibe—atherosclerosis	0.000651	0.00311	CcSEcCtD
Abacavir—Neuropathy peripheral—Pravastatin—atherosclerosis	0.000648	0.0031	CcSEcCtD
Abacavir—Myocardial infarction—Pravastatin—atherosclerosis	0.000648	0.0031	CcSEcCtD
Abacavir—ADH6—Metabolism—PLTP—atherosclerosis	0.000639	0.0118	CbGpPWpGaD
Abacavir—Chills—Lovastatin—atherosclerosis	0.00063	0.00301	CcSEcCtD
Abacavir—Cough—Rosuvastatin—atherosclerosis	0.000629	0.00301	CcSEcCtD
Abacavir—Immune system disorder—Ezetimibe—atherosclerosis	0.000622	0.00297	CcSEcCtD
Abacavir—Erythema multiforme—Simvastatin—atherosclerosis	0.000621	0.00297	CcSEcCtD
Abacavir—Alopecia—Lovastatin—atherosclerosis	0.00062	0.00297	CcSEcCtD
Abacavir—Arthralgia—Rosuvastatin—atherosclerosis	0.000614	0.00294	CcSEcCtD
Abacavir—Myalgia—Rosuvastatin—atherosclerosis	0.000614	0.00294	CcSEcCtD
Abacavir—Alopecia—Ezetimibe—atherosclerosis	0.000609	0.00291	CcSEcCtD
Abacavir—Hepatitis—Niacin—atherosclerosis	0.000603	0.00288	CcSEcCtD
Abacavir—Malnutrition—Ezetimibe—atherosclerosis	0.000599	0.00287	CcSEcCtD
Abacavir—Hepatitis—Pravastatin—atherosclerosis	0.000594	0.00284	CcSEcCtD
Abacavir—Pharyngitis—Pravastatin—atherosclerosis	0.000589	0.00282	CcSEcCtD
Abacavir—Chills—Simvastatin—atherosclerosis	0.000589	0.00282	CcSEcCtD
Abacavir—Infection—Rosuvastatin—atherosclerosis	0.000585	0.0028	CcSEcCtD
Abacavir—Alopecia—Simvastatin—atherosclerosis	0.00058	0.00278	CcSEcCtD
Abacavir—Nervous system disorder—Rosuvastatin—atherosclerosis	0.000577	0.00276	CcSEcCtD
Abacavir—Thrombocytopenia—Rosuvastatin—atherosclerosis	0.000576	0.00276	CcSEcCtD
Abacavir—Ill-defined disorder—Lovastatin—atherosclerosis	0.000567	0.00271	CcSEcCtD
Abacavir—Erythema multiforme—Pravastatin—atherosclerosis	0.000561	0.00268	CcSEcCtD
Abacavir—Ill-defined disorder—Ezetimibe—atherosclerosis	0.000556	0.00266	CcSEcCtD
Abacavir—Anaemia—Ezetimibe—atherosclerosis	0.000554	0.00265	CcSEcCtD
Abacavir—ADH6—Metabolism—ABCG8—atherosclerosis	0.000554	0.0103	CbGpPWpGaD
Abacavir—ADH6—Metabolism—LTA4H—atherosclerosis	0.000554	0.0103	CbGpPWpGaD
Abacavir—Malaise—Lovastatin—atherosclerosis	0.000551	0.00264	CcSEcCtD
Abacavir—Vertigo—Lovastatin—atherosclerosis	0.000549	0.00263	CcSEcCtD
Abacavir—Leukopenia—Lovastatin—atherosclerosis	0.000547	0.00262	CcSEcCtD
Abacavir—Chills—Niacin—atherosclerosis	0.000541	0.00259	CcSEcCtD
Abacavir—Malaise—Ezetimibe—atherosclerosis	0.000541	0.00259	CcSEcCtD
Abacavir—Musculoskeletal discomfort—Rosuvastatin—atherosclerosis	0.000536	0.00256	CcSEcCtD
Abacavir—Alopecia—Niacin—atherosclerosis	0.000533	0.00255	CcSEcCtD
Abacavir—Chills—Pravastatin—atherosclerosis	0.000533	0.00255	CcSEcCtD
Abacavir—Insomnia—Rosuvastatin—atherosclerosis	0.000532	0.00255	CcSEcCtD
Abacavir—Ill-defined disorder—Simvastatin—atherosclerosis	0.00053	0.00254	CcSEcCtD
Abacavir—Paraesthesia—Rosuvastatin—atherosclerosis	0.000529	0.00253	CcSEcCtD
Abacavir—Anaemia—Simvastatin—atherosclerosis	0.000528	0.00253	CcSEcCtD
Abacavir—Malnutrition—Niacin—atherosclerosis	0.000525	0.00251	CcSEcCtD
Abacavir—Alopecia—Pravastatin—atherosclerosis	0.000525	0.00251	CcSEcCtD
Abacavir—Cough—Ezetimibe—atherosclerosis	0.000523	0.0025	CcSEcCtD
Abacavir—Myalgia—Lovastatin—atherosclerosis	0.00052	0.00249	CcSEcCtD
Abacavir—Arthralgia—Lovastatin—atherosclerosis	0.00052	0.00249	CcSEcCtD
Abacavir—Anxiety—Lovastatin—atherosclerosis	0.000519	0.00248	CcSEcCtD
Abacavir—Malaise—Simvastatin—atherosclerosis	0.000516	0.00247	CcSEcCtD
Abacavir—Discomfort—Lovastatin—atherosclerosis	0.000514	0.00246	CcSEcCtD
Abacavir—Vertigo—Simvastatin—atherosclerosis	0.000514	0.00246	CcSEcCtD
Abacavir—Leukopenia—Simvastatin—atherosclerosis	0.000512	0.00245	CcSEcCtD
Abacavir—Arthralgia—Ezetimibe—atherosclerosis	0.00051	0.00244	CcSEcCtD
Abacavir—Myalgia—Ezetimibe—atherosclerosis	0.00051	0.00244	CcSEcCtD
Abacavir—Unspecified disorder of skin and subcutaneous tissue—Ezetimibe—atherosclerosis	0.000507	0.00242	CcSEcCtD
Abacavir—Discomfort—Ezetimibe—atherosclerosis	0.000504	0.00241	CcSEcCtD
Abacavir—Pain—Rosuvastatin—atherosclerosis	0.000503	0.00241	CcSEcCtD
Abacavir—Anaphylactic shock—Lovastatin—atherosclerosis	0.000499	0.00239	CcSEcCtD
Abacavir—Infection—Lovastatin—atherosclerosis	0.000496	0.00237	CcSEcCtD
Abacavir—Anaphylactic shock—Ezetimibe—atherosclerosis	0.000489	0.00234	CcSEcCtD
Abacavir—Thrombocytopenia—Lovastatin—atherosclerosis	0.000488	0.00234	CcSEcCtD
Abacavir—Arthralgia—Simvastatin—atherosclerosis	0.000487	0.00233	CcSEcCtD
Abacavir—Myalgia—Simvastatin—atherosclerosis	0.000487	0.00233	CcSEcCtD
Abacavir—Infection—Ezetimibe—atherosclerosis	0.000486	0.00232	CcSEcCtD
Abacavir—Feeling abnormal—Rosuvastatin—atherosclerosis	0.000485	0.00232	CcSEcCtD
Abacavir—Anxiety—Simvastatin—atherosclerosis	0.000485	0.00232	CcSEcCtD
Abacavir—Gastrointestinal pain—Rosuvastatin—atherosclerosis	0.000481	0.0023	CcSEcCtD
Abacavir—Discomfort—Simvastatin—atherosclerosis	0.000481	0.0023	CcSEcCtD
Abacavir—Nervous system disorder—Ezetimibe—atherosclerosis	0.00048	0.00229	CcSEcCtD
Abacavir—Ill-defined disorder—Pravastatin—atherosclerosis	0.00048	0.00229	CcSEcCtD
Abacavir—Thrombocytopenia—Ezetimibe—atherosclerosis	0.000479	0.00229	CcSEcCtD
Abacavir—Anaemia—Pravastatin—atherosclerosis	0.000478	0.00228	CcSEcCtD
Abacavir—Anorexia—Lovastatin—atherosclerosis	0.000475	0.00227	CcSEcCtD
Abacavir—Skin disorder—Ezetimibe—atherosclerosis	0.000475	0.00227	CcSEcCtD
Abacavir—Vertigo—Niacin—atherosclerosis	0.000472	0.00226	CcSEcCtD
Abacavir—Leukopenia—Niacin—atherosclerosis	0.00047	0.00225	CcSEcCtD
Abacavir—Urticaria—Rosuvastatin—atherosclerosis	0.000468	0.00224	CcSEcCtD
Abacavir—Anaphylactic shock—Simvastatin—atherosclerosis	0.000467	0.00223	CcSEcCtD
Abacavir—Oedema—Simvastatin—atherosclerosis	0.000467	0.00223	CcSEcCtD
Abacavir—Malaise—Pravastatin—atherosclerosis	0.000466	0.00223	CcSEcCtD
Abacavir—Abdominal pain—Rosuvastatin—atherosclerosis	0.000465	0.00223	CcSEcCtD
Abacavir—Vertigo—Pravastatin—atherosclerosis	0.000464	0.00222	CcSEcCtD
Abacavir—Infection—Simvastatin—atherosclerosis	0.000464	0.00222	CcSEcCtD
Abacavir—Leukopenia—Pravastatin—atherosclerosis	0.000463	0.00221	CcSEcCtD
Abacavir—Cough—Niacin—atherosclerosis	0.000458	0.00219	CcSEcCtD
Abacavir—Thrombocytopenia—Simvastatin—atherosclerosis	0.000457	0.00218	CcSEcCtD
Abacavir—Musculoskeletal discomfort—Lovastatin—atherosclerosis	0.000454	0.00217	CcSEcCtD
Abacavir—Insomnia—Lovastatin—atherosclerosis	0.000451	0.00216	CcSEcCtD
Abacavir—Cough—Pravastatin—atherosclerosis	0.000451	0.00216	CcSEcCtD
Abacavir—Paraesthesia—Lovastatin—atherosclerosis	0.000448	0.00214	CcSEcCtD
Abacavir—Arthralgia—Niacin—atherosclerosis	0.000447	0.00214	CcSEcCtD
Abacavir—Myalgia—Niacin—atherosclerosis	0.000447	0.00214	CcSEcCtD
Abacavir—Musculoskeletal discomfort—Ezetimibe—atherosclerosis	0.000446	0.00213	CcSEcCtD
Abacavir—Anorexia—Simvastatin—atherosclerosis	0.000445	0.00213	CcSEcCtD
Abacavir—Dyspnoea—Lovastatin—atherosclerosis	0.000445	0.00213	CcSEcCtD
Abacavir—Unspecified disorder of skin and subcutaneous tissue—Niacin—atherosclerosis	0.000444	0.00212	CcSEcCtD
Abacavir—Insomnia—Ezetimibe—atherosclerosis	0.000442	0.00212	CcSEcCtD
Abacavir—Arthralgia—Pravastatin—atherosclerosis	0.00044	0.0021	CcSEcCtD
Abacavir—Myalgia—Pravastatin—atherosclerosis	0.00044	0.0021	CcSEcCtD
Abacavir—Paraesthesia—Ezetimibe—atherosclerosis	0.000439	0.0021	CcSEcCtD
Abacavir—Anxiety—Pravastatin—atherosclerosis	0.000438	0.0021	CcSEcCtD
Abacavir—ADH6—Metabolism—ABCG1—atherosclerosis	0.000438	0.00812	CbGpPWpGaD
Abacavir—Dyspnoea—Ezetimibe—atherosclerosis	0.000436	0.00209	CcSEcCtD
Abacavir—Discomfort—Pravastatin—atherosclerosis	0.000435	0.00208	CcSEcCtD
Abacavir—Hypersensitivity—Rosuvastatin—atherosclerosis	0.000434	0.00207	CcSEcCtD
Abacavir—Decreased appetite—Lovastatin—atherosclerosis	0.000434	0.00207	CcSEcCtD
Abacavir—Fatigue—Lovastatin—atherosclerosis	0.00043	0.00206	CcSEcCtD
Abacavir—Anaphylactic shock—Niacin—atherosclerosis	0.000428	0.00205	CcSEcCtD
Abacavir—Oedema—Niacin—atherosclerosis	0.000428	0.00205	CcSEcCtD
Abacavir—Pain—Lovastatin—atherosclerosis	0.000427	0.00204	CcSEcCtD
Abacavir—Decreased appetite—Ezetimibe—atherosclerosis	0.000425	0.00203	CcSEcCtD
Abacavir—Musculoskeletal discomfort—Simvastatin—atherosclerosis	0.000425	0.00203	CcSEcCtD
Abacavir—Gastrointestinal disorder—Ezetimibe—atherosclerosis	0.000422	0.00202	CcSEcCtD
Abacavir—Asthenia—Rosuvastatin—atherosclerosis	0.000422	0.00202	CcSEcCtD
Abacavir—Insomnia—Simvastatin—atherosclerosis	0.000422	0.00202	CcSEcCtD
Abacavir—Anaphylactic shock—Pravastatin—atherosclerosis	0.000422	0.00202	CcSEcCtD
Abacavir—Oedema—Pravastatin—atherosclerosis	0.000422	0.00202	CcSEcCtD
Abacavir—Fatigue—Ezetimibe—atherosclerosis	0.000422	0.00202	CcSEcCtD
Abacavir—Infection—Pravastatin—atherosclerosis	0.000419	0.002	CcSEcCtD
Abacavir—Paraesthesia—Simvastatin—atherosclerosis	0.000419	0.002	CcSEcCtD
Abacavir—Pain—Ezetimibe—atherosclerosis	0.000418	0.002	CcSEcCtD
Abacavir—Pruritus—Rosuvastatin—atherosclerosis	0.000416	0.00199	CcSEcCtD
Abacavir—Skin disorder—Niacin—atherosclerosis	0.000416	0.00199	CcSEcCtD
Abacavir—Dyspnoea—Simvastatin—atherosclerosis	0.000416	0.00199	CcSEcCtD
Abacavir—Thrombocytopenia—Pravastatin—atherosclerosis	0.000413	0.00198	CcSEcCtD
Abacavir—ADH6—Metabolism—LCAT—atherosclerosis	0.000412	0.00763	CbGpPWpGaD
Abacavir—ADH6—Metabolism—FABP4—atherosclerosis	0.000412	0.00763	CbGpPWpGaD
Abacavir—Feeling abnormal—Lovastatin—atherosclerosis	0.000411	0.00197	CcSEcCtD
Abacavir—Anorexia—Niacin—atherosclerosis	0.000408	0.00195	CcSEcCtD
Abacavir—Gastrointestinal pain—Lovastatin—atherosclerosis	0.000408	0.00195	CcSEcCtD
Abacavir—Decreased appetite—Simvastatin—atherosclerosis	0.000406	0.00194	CcSEcCtD
Abacavir—ADH6—Metabolism—APOA4—atherosclerosis	0.000404	0.00749	CbGpPWpGaD
Abacavir—Feeling abnormal—Ezetimibe—atherosclerosis	0.000403	0.00193	CcSEcCtD
Abacavir—Gastrointestinal disorder—Simvastatin—atherosclerosis	0.000403	0.00193	CcSEcCtD
Abacavir—Diarrhoea—Rosuvastatin—atherosclerosis	0.000403	0.00193	CcSEcCtD
Abacavir—Fatigue—Simvastatin—atherosclerosis	0.000402	0.00192	CcSEcCtD
Abacavir—Anorexia—Pravastatin—atherosclerosis	0.000402	0.00192	CcSEcCtD
Abacavir—Hypotension—Niacin—atherosclerosis	0.0004	0.00191	CcSEcCtD
Abacavir—Gastrointestinal pain—Ezetimibe—atherosclerosis	0.0004	0.00191	CcSEcCtD
Abacavir—Pain—Simvastatin—atherosclerosis	0.000399	0.00191	CcSEcCtD
Abacavir—ADH6—Metabolism—CYP7A1—atherosclerosis	0.000397	0.00736	CbGpPWpGaD
Abacavir—Urticaria—Lovastatin—atherosclerosis	0.000396	0.0019	CcSEcCtD
Abacavir—Abdominal pain—Lovastatin—atherosclerosis	0.000394	0.00189	CcSEcCtD
Abacavir—Body temperature increased—Lovastatin—atherosclerosis	0.000394	0.00189	CcSEcCtD
Abacavir—Musculoskeletal discomfort—Niacin—atherosclerosis	0.00039	0.00187	CcSEcCtD
Abacavir—Dizziness—Rosuvastatin—atherosclerosis	0.000389	0.00186	CcSEcCtD
Abacavir—Urticaria—Ezetimibe—atherosclerosis	0.000389	0.00186	CcSEcCtD
Abacavir—Insomnia—Niacin—atherosclerosis	0.000387	0.00185	CcSEcCtD
Abacavir—Abdominal pain—Ezetimibe—atherosclerosis	0.000387	0.00185	CcSEcCtD
Abacavir—Body temperature increased—Ezetimibe—atherosclerosis	0.000387	0.00185	CcSEcCtD
Abacavir—Paraesthesia—Niacin—atherosclerosis	0.000385	0.00184	CcSEcCtD
Abacavir—Feeling abnormal—Simvastatin—atherosclerosis	0.000384	0.00184	CcSEcCtD
Abacavir—Musculoskeletal discomfort—Pravastatin—atherosclerosis	0.000384	0.00184	CcSEcCtD
Abacavir—Dyspnoea—Niacin—atherosclerosis	0.000382	0.00183	CcSEcCtD
Abacavir—Gastrointestinal pain—Simvastatin—atherosclerosis	0.000382	0.00182	CcSEcCtD
Abacavir—Insomnia—Pravastatin—atherosclerosis	0.000382	0.00182	CcSEcCtD
Abacavir—Paraesthesia—Pravastatin—atherosclerosis	0.000379	0.00181	CcSEcCtD
Abacavir—Dyspnoea—Pravastatin—atherosclerosis	0.000376	0.0018	CcSEcCtD
Abacavir—Decreased appetite—Niacin—atherosclerosis	0.000372	0.00178	CcSEcCtD
Abacavir—Rash—Rosuvastatin—atherosclerosis	0.000371	0.00177	CcSEcCtD
Abacavir—Dermatitis—Rosuvastatin—atherosclerosis	0.000371	0.00177	CcSEcCtD
Abacavir—Urticaria—Simvastatin—atherosclerosis	0.000371	0.00177	CcSEcCtD
Abacavir—Gastrointestinal disorder—Niacin—atherosclerosis	0.00037	0.00177	CcSEcCtD
Abacavir—Body temperature increased—Simvastatin—atherosclerosis	0.000369	0.00176	CcSEcCtD
Abacavir—Abdominal pain—Simvastatin—atherosclerosis	0.000369	0.00176	CcSEcCtD
Abacavir—Headache—Rosuvastatin—atherosclerosis	0.000369	0.00176	CcSEcCtD
Abacavir—Hypersensitivity—Lovastatin—atherosclerosis	0.000367	0.00176	CcSEcCtD
Abacavir—ADH6—Metabolism—CYP27A1—atherosclerosis	0.000367	0.0068	CbGpPWpGaD
Abacavir—UGT1A1—Biological oxidations—CYP7A1—atherosclerosis	0.000367	0.0068	CbGpPWpGaD
Abacavir—Decreased appetite—Pravastatin—atherosclerosis	0.000367	0.00175	CcSEcCtD
Abacavir—Pain—Niacin—atherosclerosis	0.000366	0.00175	CcSEcCtD
Abacavir—Fatigue—Pravastatin—atherosclerosis	0.000364	0.00174	CcSEcCtD
Abacavir—ADK—Metabolism—LDLRAP1—atherosclerosis	0.000363	0.00673	CbGpPWpGaD
Abacavir—UGT1A1—Metapathway biotransformation—CYP7A1—atherosclerosis	0.000362	0.00671	CbGpPWpGaD
Abacavir—Pain—Pravastatin—atherosclerosis	0.000361	0.00173	CcSEcCtD
Abacavir—Hypersensitivity—Ezetimibe—atherosclerosis	0.00036	0.00172	CcSEcCtD
Abacavir—Asthenia—Lovastatin—atherosclerosis	0.000358	0.00171	CcSEcCtD
Abacavir—Pruritus—Lovastatin—atherosclerosis	0.000353	0.00169	CcSEcCtD
Abacavir—Asthenia—Ezetimibe—atherosclerosis	0.000351	0.00168	CcSEcCtD
Abacavir—Gastrointestinal pain—Niacin—atherosclerosis	0.00035	0.00168	CcSEcCtD
Abacavir—Nausea—Rosuvastatin—atherosclerosis	0.00035	0.00167	CcSEcCtD
Abacavir—ADH6—Metabolism—PLA2G2A—atherosclerosis	0.000348	0.00645	CbGpPWpGaD
Abacavir—ADH6—Metabolism—ALOX15—atherosclerosis	0.000348	0.00645	CbGpPWpGaD
Abacavir—ADH6—Metabolism—ALOX5AP—atherosclerosis	0.000348	0.00645	CbGpPWpGaD
Abacavir—ADH6—Metabolism—APOA2—atherosclerosis	0.000348	0.00645	CbGpPWpGaD
Abacavir—Feeling abnormal—Pravastatin—atherosclerosis	0.000348	0.00166	CcSEcCtD
Abacavir—Pruritus—Ezetimibe—atherosclerosis	0.000346	0.00166	CcSEcCtD
Abacavir—Gastrointestinal pain—Pravastatin—atherosclerosis	0.000345	0.00165	CcSEcCtD
Abacavir—Hypersensitivity—Simvastatin—atherosclerosis	0.000344	0.00164	CcSEcCtD
Abacavir—ADH6—Metabolism—ABCG5—atherosclerosis	0.000344	0.00637	CbGpPWpGaD
Abacavir—Diarrhoea—Lovastatin—atherosclerosis	0.000341	0.00163	CcSEcCtD
Abacavir—ADK—Metabolism—PLTP—atherosclerosis	0.000341	0.00633	CbGpPWpGaD
Abacavir—Urticaria—Niacin—atherosclerosis	0.00034	0.00163	CcSEcCtD
Abacavir—UGT1A1—Biological oxidations—CYP27A1—atherosclerosis	0.000339	0.00629	CbGpPWpGaD
Abacavir—Abdominal pain—Niacin—atherosclerosis	0.000339	0.00162	CcSEcCtD
Abacavir—Body temperature increased—Niacin—atherosclerosis	0.000339	0.00162	CcSEcCtD
Abacavir—Urticaria—Pravastatin—atherosclerosis	0.000335	0.0016	CcSEcCtD
Abacavir—Asthenia—Simvastatin—atherosclerosis	0.000335	0.0016	CcSEcCtD
Abacavir—Diarrhoea—Ezetimibe—atherosclerosis	0.000335	0.0016	CcSEcCtD
Abacavir—UGT1A1—Metapathway biotransformation—CYP27A1—atherosclerosis	0.000334	0.0062	CbGpPWpGaD
Abacavir—Abdominal pain—Pravastatin—atherosclerosis	0.000333	0.00159	CcSEcCtD
Abacavir—Body temperature increased—Pravastatin—atherosclerosis	0.000333	0.00159	CcSEcCtD
Abacavir—ADH6—Metabolism—LPA—atherosclerosis	0.000332	0.00615	CbGpPWpGaD
Abacavir—Pruritus—Simvastatin—atherosclerosis	0.00033	0.00158	CcSEcCtD
Abacavir—Dizziness—Lovastatin—atherosclerosis	0.00033	0.00158	CcSEcCtD
Abacavir—Dizziness—Ezetimibe—atherosclerosis	0.000324	0.00155	CcSEcCtD
Abacavir—ADH6—Metabolism—BGN—atherosclerosis	0.000321	0.00596	CbGpPWpGaD
Abacavir—Diarrhoea—Simvastatin—atherosclerosis	0.000319	0.00153	CcSEcCtD
Abacavir—ADH6—Metabolism—APOA5—atherosclerosis	0.000318	0.0059	CbGpPWpGaD
Abacavir—Vomiting—Lovastatin—atherosclerosis	0.000317	0.00152	CcSEcCtD
Abacavir—Hypersensitivity—Niacin—atherosclerosis	0.000316	0.00151	CcSEcCtD
Abacavir—Rash—Lovastatin—atherosclerosis	0.000314	0.0015	CcSEcCtD
Abacavir—Dermatitis—Lovastatin—atherosclerosis	0.000314	0.0015	CcSEcCtD
Abacavir—Headache—Lovastatin—atherosclerosis	0.000312	0.00149	CcSEcCtD
Abacavir—Vomiting—Ezetimibe—atherosclerosis	0.000311	0.00149	CcSEcCtD
Abacavir—Hypersensitivity—Pravastatin—atherosclerosis	0.000311	0.00149	CcSEcCtD
Abacavir—Dizziness—Simvastatin—atherosclerosis	0.000309	0.00148	CcSEcCtD
Abacavir—Rash—Ezetimibe—atherosclerosis	0.000308	0.00148	CcSEcCtD
Abacavir—Dermatitis—Ezetimibe—atherosclerosis	0.000308	0.00147	CcSEcCtD
Abacavir—Asthenia—Niacin—atherosclerosis	0.000307	0.00147	CcSEcCtD
Abacavir—Headache—Ezetimibe—atherosclerosis	0.000306	0.00147	CcSEcCtD
Abacavir—ADH6—Metabolism—PLA2G1B—atherosclerosis	0.000306	0.00568	CbGpPWpGaD
Abacavir—Pruritus—Niacin—atherosclerosis	0.000303	0.00145	CcSEcCtD
Abacavir—Asthenia—Pravastatin—atherosclerosis	0.000303	0.00145	CcSEcCtD
Abacavir—Pruritus—Pravastatin—atherosclerosis	0.000298	0.00143	CcSEcCtD
Abacavir—Vomiting—Simvastatin—atherosclerosis	0.000297	0.00142	CcSEcCtD
Abacavir—Nausea—Lovastatin—atherosclerosis	0.000296	0.00142	CcSEcCtD
Abacavir—ADK—Metabolism—LTA4H—atherosclerosis	0.000296	0.00549	CbGpPWpGaD
Abacavir—ADH6—Metabolism—ALOX5—atherosclerosis	0.000296	0.00549	CbGpPWpGaD
Abacavir—ADK—Metabolism—ABCG8—atherosclerosis	0.000296	0.00549	CbGpPWpGaD
Abacavir—Rash—Simvastatin—atherosclerosis	0.000294	0.00141	CcSEcCtD
Abacavir—Dermatitis—Simvastatin—atherosclerosis	0.000294	0.00141	CcSEcCtD
Abacavir—Diarrhoea—Niacin—atherosclerosis	0.000293	0.0014	CcSEcCtD
Abacavir—Headache—Simvastatin—atherosclerosis	0.000292	0.0014	CcSEcCtD
Abacavir—Nausea—Ezetimibe—atherosclerosis	0.000291	0.00139	CcSEcCtD
Abacavir—Diarrhoea—Pravastatin—atherosclerosis	0.000289	0.00138	CcSEcCtD
Abacavir—Dizziness—Niacin—atherosclerosis	0.000283	0.00135	CcSEcCtD
Abacavir—Dizziness—Pravastatin—atherosclerosis	0.000279	0.00133	CcSEcCtD
Abacavir—Nausea—Simvastatin—atherosclerosis	0.000277	0.00133	CcSEcCtD
Abacavir—Vomiting—Niacin—atherosclerosis	0.000272	0.0013	CcSEcCtD
Abacavir—Rash—Niacin—atherosclerosis	0.00027	0.00129	CcSEcCtD
Abacavir—Dermatitis—Niacin—atherosclerosis	0.00027	0.00129	CcSEcCtD
Abacavir—Headache—Niacin—atherosclerosis	0.000268	0.00128	CcSEcCtD
Abacavir—Vomiting—Pravastatin—atherosclerosis	0.000268	0.00128	CcSEcCtD
Abacavir—Rash—Pravastatin—atherosclerosis	0.000266	0.00127	CcSEcCtD
Abacavir—Dermatitis—Pravastatin—atherosclerosis	0.000266	0.00127	CcSEcCtD
Abacavir—ADH6—Metabolism—NAMPT—atherosclerosis	0.000265	0.00492	CbGpPWpGaD
Abacavir—Headache—Pravastatin—atherosclerosis	0.000264	0.00126	CcSEcCtD
Abacavir—ADH6—Metabolism—LIPC—atherosclerosis	0.000264	0.00489	CbGpPWpGaD
Abacavir—ADH6—Metabolism—APOC3—atherosclerosis	0.000262	0.00486	CbGpPWpGaD
Abacavir—ADH6—Metabolism—LDLR—atherosclerosis	0.00026	0.00483	CbGpPWpGaD
Abacavir—UGT1A1—Phase II conjugation—GSTM1—atherosclerosis	0.000259	0.0048	CbGpPWpGaD
Abacavir—UGT1A1—Aryl Hydrocarbon Receptor Pathway—IFNG—atherosclerosis	0.000256	0.00474	CbGpPWpGaD
Abacavir—Nausea—Niacin—atherosclerosis	0.000254	0.00122	CcSEcCtD
Abacavir—ADH6—Metabolism—CETP—atherosclerosis	0.000254	0.00472	CbGpPWpGaD
Abacavir—Nausea—Pravastatin—atherosclerosis	0.000251	0.0012	CcSEcCtD
Abacavir—ADH6—Metabolism—SCARB1—atherosclerosis	0.000244	0.00452	CbGpPWpGaD
Abacavir—ADK—Metabolism—ABCG1—atherosclerosis	0.000234	0.00434	CbGpPWpGaD
Abacavir—ADH6—Metabolism—HMGCR—atherosclerosis	0.00023	0.00427	CbGpPWpGaD
Abacavir—UGT1A1—Aryl Hydrocarbon Receptor Pathway—IL1B—atherosclerosis	0.000228	0.00423	CbGpPWpGaD
Abacavir—ADK—Metabolism—FABP4—atherosclerosis	0.00022	0.00408	CbGpPWpGaD
Abacavir—ADK—Metabolism—LCAT—atherosclerosis	0.00022	0.00408	CbGpPWpGaD
Abacavir—ADK—Metabolism—APOA4—atherosclerosis	0.000216	0.004	CbGpPWpGaD
Abacavir—ADK—Metabolism—CYP7A1—atherosclerosis	0.000212	0.00393	CbGpPWpGaD
Abacavir—ADH6—Metabolism—ABCA1—atherosclerosis	0.000205	0.0038	CbGpPWpGaD
Abacavir—ADK—Metabolism—CYP27A1—atherosclerosis	0.000196	0.00363	CbGpPWpGaD
Abacavir—ADK—Metabolism—ALOX15—atherosclerosis	0.000186	0.00344	CbGpPWpGaD
Abacavir—ADK—Metabolism—PLA2G2A—atherosclerosis	0.000186	0.00344	CbGpPWpGaD
Abacavir—ADK—Metabolism—APOA2—atherosclerosis	0.000186	0.00344	CbGpPWpGaD
Abacavir—ADK—Metabolism—ALOX5AP—atherosclerosis	0.000186	0.00344	CbGpPWpGaD
Abacavir—UGT1A1—NRF2 pathway—HMOX1—atherosclerosis	0.000185	0.00344	CbGpPWpGaD
Abacavir—ADK—Metabolism—ABCG5—atherosclerosis	0.000183	0.0034	CbGpPWpGaD
Abacavir—UGT1A1—Aryl Hydrocarbon Receptor Pathway—TGFB1—atherosclerosis	0.000177	0.00329	CbGpPWpGaD
Abacavir—ADK—Metabolism—LPA—atherosclerosis	0.000177	0.00329	CbGpPWpGaD
Abacavir—ADH6—Metabolism—HMOX1—atherosclerosis	0.000176	0.00326	CbGpPWpGaD
Abacavir—UGT1A1—NRF2 pathway—GSTM1—atherosclerosis	0.000173	0.0032	CbGpPWpGaD
Abacavir—ADK—Metabolism—BGN—atherosclerosis	0.000172	0.00318	CbGpPWpGaD
Abacavir—ADK—Metabolism—APOA5—atherosclerosis	0.00017	0.00315	CbGpPWpGaD
Abacavir—ADH6—Metabolism—APOB—atherosclerosis	0.000168	0.00312	CbGpPWpGaD
Abacavir—UGT1A1—NRF2 pathway—AGER—atherosclerosis	0.000166	0.00309	CbGpPWpGaD
Abacavir—UGT1A1—Aryl Hydrocarbon Receptor Pathway—TNF—atherosclerosis	0.000165	0.00307	CbGpPWpGaD
Abacavir—ADH6—Metabolism—GSTM1—atherosclerosis	0.000164	0.00304	CbGpPWpGaD
Abacavir—ADK—Metabolism—PLA2G1B—atherosclerosis	0.000164	0.00303	CbGpPWpGaD
Abacavir—ADH6—Metabolism—LPL—atherosclerosis	0.000161	0.00298	CbGpPWpGaD
Abacavir—ADK—Metabolism—ALOX5—atherosclerosis	0.000158	0.00293	CbGpPWpGaD
Abacavir—ADH6—Metabolism—GPX1—atherosclerosis	0.000157	0.00291	CbGpPWpGaD
Abacavir—ADH6—Metabolism—CD36—atherosclerosis	0.000153	0.00283	CbGpPWpGaD
Abacavir—UGT1A1—Biological oxidations—GSTM1—atherosclerosis	0.000151	0.00281	CbGpPWpGaD
Abacavir—UGT1A1—Metapathway biotransformation—GSTM1—atherosclerosis	0.000149	0.00277	CbGpPWpGaD
Abacavir—UGT1A1—NRF2 pathway—PDGFB—atherosclerosis	0.000148	0.00275	CbGpPWpGaD
Abacavir—ADH6—Metabolism—MTHFR—atherosclerosis	0.000145	0.00269	CbGpPWpGaD
Abacavir—ADH6—Metabolism—PPARA—atherosclerosis	0.000142	0.00264	CbGpPWpGaD
Abacavir—ADK—Metabolism—NAMPT—atherosclerosis	0.000142	0.00263	CbGpPWpGaD
Abacavir—ADK—Metabolism—LIPC—atherosclerosis	0.000141	0.00261	CbGpPWpGaD
Abacavir—ADK—Metabolism—APOC3—atherosclerosis	0.00014	0.00259	CbGpPWpGaD
Abacavir—ADK—Metabolism—LDLR—atherosclerosis	0.000139	0.00258	CbGpPWpGaD
Abacavir—ADH6—Metabolism—AGT—atherosclerosis	0.000138	0.00255	CbGpPWpGaD
Abacavir—ADK—Metabolism—CETP—atherosclerosis	0.000136	0.00252	CbGpPWpGaD
Abacavir—ADH6—Metabolism—APOE—atherosclerosis	0.000135	0.0025	CbGpPWpGaD
Abacavir—ADH6—Metabolism—CAV1—atherosclerosis	0.000134	0.00248	CbGpPWpGaD
Abacavir—ADH6—Metabolism—APOA1—atherosclerosis	0.000133	0.00247	CbGpPWpGaD
Abacavir—ADK—Metabolism—SCARB1—atherosclerosis	0.00013	0.00241	CbGpPWpGaD
Abacavir—ADK—Metabolism—HMGCR—atherosclerosis	0.000123	0.00228	CbGpPWpGaD
Abacavir—ADH6—Metabolism—PIK3CG—atherosclerosis	0.000122	0.00226	CbGpPWpGaD
Abacavir—ADH6—Metabolism—PPARG—atherosclerosis	0.000117	0.00218	CbGpPWpGaD
Abacavir—ADH6—Metabolism—INS—atherosclerosis	0.000115	0.00214	CbGpPWpGaD
Abacavir—ADK—Metabolism—ABCA1—atherosclerosis	0.000109	0.00203	CbGpPWpGaD
Abacavir—UGT1A1—Metabolism—LDLRAP1—atherosclerosis	0.000107	0.00199	CbGpPWpGaD
Abacavir—ADH6—Metabolism—ALB—atherosclerosis	0.000106	0.00196	CbGpPWpGaD
Abacavir—ADH6—Metabolism—NOS3—atherosclerosis	0.000101	0.00187	CbGpPWpGaD
Abacavir—UGT1A1—Metabolism—PLTP—atherosclerosis	0.000101	0.00187	CbGpPWpGaD
Abacavir—ADK—Metabolism—HMOX1—atherosclerosis	9.39e-05	0.00174	CbGpPWpGaD
Abacavir—ADH6—Metabolism—PTGS2—atherosclerosis	9.24e-05	0.00171	CbGpPWpGaD
Abacavir—ADK—Metabolism—APOB—atherosclerosis	9e-05	0.00167	CbGpPWpGaD
Abacavir—ADK—Metabolism—GSTM1—atherosclerosis	8.75e-05	0.00162	CbGpPWpGaD
Abacavir—UGT1A1—Metabolism—ABCG8—atherosclerosis	8.75e-05	0.00162	CbGpPWpGaD
Abacavir—UGT1A1—Metabolism—LTA4H—atherosclerosis	8.75e-05	0.00162	CbGpPWpGaD
Abacavir—ADK—Metabolism—LPL—atherosclerosis	8.59e-05	0.00159	CbGpPWpGaD
Abacavir—ADK—Metabolism—GPX1—atherosclerosis	8.38e-05	0.00155	CbGpPWpGaD
Abacavir—ADK—Metabolism—CD36—atherosclerosis	8.16e-05	0.00151	CbGpPWpGaD
Abacavir—ADK—Metabolism—MTHFR—atherosclerosis	7.73e-05	0.00143	CbGpPWpGaD
Abacavir—ADK—Metabolism—PPARA—atherosclerosis	7.59e-05	0.00141	CbGpPWpGaD
Abacavir—ADK—Metabolism—AGT—atherosclerosis	7.35e-05	0.00136	CbGpPWpGaD
Abacavir—ADK—Metabolism—APOE—atherosclerosis	7.2e-05	0.00134	CbGpPWpGaD
Abacavir—ADK—Metabolism—CAV1—atherosclerosis	7.13e-05	0.00132	CbGpPWpGaD
Abacavir—ADK—Metabolism—APOA1—atherosclerosis	7.12e-05	0.00132	CbGpPWpGaD
Abacavir—UGT1A1—NRF2 pathway—TGFB1—atherosclerosis	7.04e-05	0.0013	CbGpPWpGaD
Abacavir—UGT1A1—Metabolism—ABCG1—atherosclerosis	6.92e-05	0.00128	CbGpPWpGaD
Abacavir—UGT1A1—Metabolism—LCAT—atherosclerosis	6.5e-05	0.00121	CbGpPWpGaD
Abacavir—UGT1A1—Metabolism—FABP4—atherosclerosis	6.5e-05	0.00121	CbGpPWpGaD
Abacavir—ADK—Metabolism—PIK3CG—atherosclerosis	6.5e-05	0.00121	CbGpPWpGaD
Abacavir—UGT1A1—Metabolism—APOA4—atherosclerosis	6.38e-05	0.00118	CbGpPWpGaD
Abacavir—UGT1A1—Metabolism—CYP7A1—atherosclerosis	6.27e-05	0.00116	CbGpPWpGaD
Abacavir—ADK—Metabolism—PPARG—atherosclerosis	6.27e-05	0.00116	CbGpPWpGaD
Abacavir—ADK—Metabolism—INS—atherosclerosis	6.15e-05	0.00114	CbGpPWpGaD
Abacavir—UGT1A1—Metabolism—CYP27A1—atherosclerosis	5.8e-05	0.00108	CbGpPWpGaD
Abacavir—ADK—Metabolism—ALB—atherosclerosis	5.64e-05	0.00105	CbGpPWpGaD
Abacavir—UGT1A1—Metabolism—PLA2G2A—atherosclerosis	5.5e-05	0.00102	CbGpPWpGaD
Abacavir—UGT1A1—Metabolism—ALOX5AP—atherosclerosis	5.5e-05	0.00102	CbGpPWpGaD
Abacavir—UGT1A1—Metabolism—APOA2—atherosclerosis	5.5e-05	0.00102	CbGpPWpGaD
Abacavir—UGT1A1—Metabolism—ALOX15—atherosclerosis	5.5e-05	0.00102	CbGpPWpGaD
Abacavir—UGT1A1—Metabolism—ABCG5—atherosclerosis	5.43e-05	0.00101	CbGpPWpGaD
Abacavir—ADK—Metabolism—NOS3—atherosclerosis	5.39e-05	0.001	CbGpPWpGaD
Abacavir—UGT1A1—Metabolism—LPA—atherosclerosis	5.24e-05	0.000972	CbGpPWpGaD
Abacavir—UGT1A1—Metabolism—BGN—atherosclerosis	5.08e-05	0.000942	CbGpPWpGaD
Abacavir—UGT1A1—Metabolism—APOA5—atherosclerosis	5.03e-05	0.000932	CbGpPWpGaD
Abacavir—ADK—Metabolism—PTGS2—atherosclerosis	4.93e-05	0.000915	CbGpPWpGaD
Abacavir—UGT1A1—Metabolism—PLA2G1B—atherosclerosis	4.84e-05	0.000897	CbGpPWpGaD
Abacavir—UGT1A1—Metabolism—ALOX5—atherosclerosis	4.67e-05	0.000867	CbGpPWpGaD
Abacavir—ADH6—Metabolism—AKT1—atherosclerosis	4.64e-05	0.000861	CbGpPWpGaD
Abacavir—UGT1A1—Metabolism—NAMPT—atherosclerosis	4.19e-05	0.000777	CbGpPWpGaD
Abacavir—UGT1A1—Metabolism—LIPC—atherosclerosis	4.16e-05	0.000772	CbGpPWpGaD
Abacavir—UGT1A1—Metabolism—APOC3—atherosclerosis	4.14e-05	0.000768	CbGpPWpGaD
Abacavir—UGT1A1—Metabolism—LDLR—atherosclerosis	4.11e-05	0.000763	CbGpPWpGaD
Abacavir—UGT1A1—Metabolism—CETP—atherosclerosis	4.02e-05	0.000745	CbGpPWpGaD
Abacavir—UGT1A1—Metabolism—SCARB1—atherosclerosis	3.85e-05	0.000714	CbGpPWpGaD
Abacavir—UGT1A1—Metabolism—HMGCR—atherosclerosis	3.63e-05	0.000674	CbGpPWpGaD
Abacavir—UGT1A1—Metabolism—ABCA1—atherosclerosis	3.24e-05	0.000601	CbGpPWpGaD
Abacavir—UGT1A1—Metabolism—HMOX1—atherosclerosis	2.78e-05	0.000515	CbGpPWpGaD
Abacavir—UGT1A1—Metabolism—APOB—atherosclerosis	2.66e-05	0.000494	CbGpPWpGaD
Abacavir—UGT1A1—Metabolism—GSTM1—atherosclerosis	2.59e-05	0.00048	CbGpPWpGaD
Abacavir—UGT1A1—Metabolism—LPL—atherosclerosis	2.54e-05	0.000471	CbGpPWpGaD
Abacavir—ADK—Metabolism—AKT1—atherosclerosis	2.48e-05	0.00046	CbGpPWpGaD
Abacavir—UGT1A1—Metabolism—GPX1—atherosclerosis	2.48e-05	0.00046	CbGpPWpGaD
Abacavir—UGT1A1—Metabolism—CD36—atherosclerosis	2.41e-05	0.000448	CbGpPWpGaD
Abacavir—UGT1A1—Metabolism—MTHFR—atherosclerosis	2.29e-05	0.000424	CbGpPWpGaD
Abacavir—UGT1A1—Metabolism—PPARA—atherosclerosis	2.24e-05	0.000416	CbGpPWpGaD
Abacavir—UGT1A1—Metabolism—AGT—atherosclerosis	2.17e-05	0.000403	CbGpPWpGaD
Abacavir—UGT1A1—Metabolism—APOE—atherosclerosis	2.13e-05	0.000395	CbGpPWpGaD
Abacavir—UGT1A1—Metabolism—CAV1—atherosclerosis	2.11e-05	0.000391	CbGpPWpGaD
Abacavir—UGT1A1—Metabolism—APOA1—atherosclerosis	2.11e-05	0.000391	CbGpPWpGaD
Abacavir—UGT1A1—Metabolism—PIK3CG—atherosclerosis	1.92e-05	0.000357	CbGpPWpGaD
Abacavir—UGT1A1—Metabolism—PPARG—atherosclerosis	1.86e-05	0.000344	CbGpPWpGaD
Abacavir—UGT1A1—Metabolism—INS—atherosclerosis	1.82e-05	0.000338	CbGpPWpGaD
Abacavir—UGT1A1—Metabolism—ALB—atherosclerosis	1.67e-05	0.000309	CbGpPWpGaD
Abacavir—UGT1A1—Metabolism—NOS3—atherosclerosis	1.6e-05	0.000296	CbGpPWpGaD
Abacavir—UGT1A1—Metabolism—PTGS2—atherosclerosis	1.46e-05	0.000271	CbGpPWpGaD
Abacavir—UGT1A1—Metabolism—AKT1—atherosclerosis	7.34e-06	0.000136	CbGpPWpGaD
